logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Long-chain-fatty-acid--CoA ligase 1

UniprotKB/SwissProt ID: ACSL1_MOUSE (P41216)

Gene Name: Acsl1

Synonyms: Acsl2, Facl2

Organism: Mus musculus (Mouse).

Function: Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses oleate, arachidonate, eicosapentaenoate and docosahexaenoate as substrates (By similarity).

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Mitochondrion outer membrane; Single-pass type III membrane protein (By similarity). Peroxisome membrane; Single-pass type III membrane protein (By similarity). Microsome membrane; Single-pass type III membrane protein (By similarity). Endoplasmic reticu

Network with metabolic pathway:
Kegg map ID Pathway Link
map00071Fatty acid metabolism
map03320PPAR signaling pathway
map04920Adipocytokine signaling pathway
map04146Peroxisome
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR000873

The S-nitrosylation sites of ACSL1_MOUSE

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
155ATRPKALKPP C DLSMQSVEIA HCCCCCCHHH H HHHHHHHCCC 12.79%MC1322178444-
255ATRPKALKPP C DLSMQSVEIA HCCCCCCHHH H HHHHHHHCCC 12.79%MC1321278135in vitro
355ATRPKALKPP C DLSMQSVEIA HCCCCCCHHH H HHHHHHHCCC 12.79%MC1320837516in vivo
455ATRPKALKPP C DLSMQSVEIA HCCCCCCHHH H HHHHHHHCCC 12.79%MC1322865876in vivo
5109RGIQVSNNGP C LGSRKPNQPY HHHHHCCCCE E EEECCCCCCE 7.72%MC0422178444-
6109RGIQVSNNGP C LGSRKPNQPY HHHHHCCCCE E EEECCCCCCE 7.72%MC0421278135in vitro
7109RGIQVSNNGP C LGSRKPNQPY HHHHHCCCCE E EEECCCCCCE 7.72%MC0420837516in vivo
8109RGIQVSNNGP C LGSRKPNQPY HHHHHCCCCE E EEECCCCCCE 7.72%MC0422865876in vivo
9133SYKEVAELAE C IGSGLIQKGF CHHHHHHHHH H HHHHHHHCCC 3.38%MC1321278135in vitro
10133SYKEVAELAE C IGSGLIQKGF CHHHHHHHHH H HHHHHHHCCC 3.38%MC1322865876in vivo
11221LEGVENKLTP C LKIIVIMDSY HHHHHHHCCC C CCEEEEEECC 5.21%MC0621278135in vitro
12221LEGVENKLTP C LKIIVIMDSY HHHHHHHCCC C CCEEEEEECC 5.21%MC0622865876in vivo
13242GSDLVERGKK C GVEIISLKAL CCCCCCCCCC C CCCCCCCHHH 9.34%MC0922178444-
14242GSDLVERGKK C GVEIISLKAL CCCCCCCCCC C CCCCCCCHHH 9.34%MC0921278135in vitro
15242GSDLVERGKK C GVEIISLKAL CCCCCCCCCC C CCCCCCCHHH 9.34%MC0920837516in vivo
16242GSDLVERGKK C GVEIISLKAL CCCCCCCCCC C CCCCCCCHHH 9.34%MC0922865876in vivo
17275PPEPEDLAII C FTSGTTGNPK CCCCCCEEEE E ECCCCCCCCC 2.19%MC1321278135in vitro
18275PPEPEDLAII C FTSGTTGNPK CCCCCCEEEE E ECCCCCCCCC 2.19%MC1322865876in vivo
19298MITHQNIIND C SGFIKATESA EEEHHHHHHH H HHHHHHHHHC 3.56%MC0122178444-
20298MITHQNIIND C SGFIKATESA EEEHHHHHHH H HHHHHHHHHC 3.56%MC0121278135in vitro
21298MITHQNIIND C SGFIKATESA EEEHHHHHHH H HHHHHHHHHC 3.56%MC0120837516in vivo
22298MITHQNIIND C SGFIKATESA EEEHHHHHHH H HHHHHHHHHC 3.56%MC0122865876in vivo
23510YLASKGEGEV C VKGANVFKGY ECCCCCEEEE E ECCCCEECCC 1.97%MC0621278135in vitro
24626RGLQGSFEEL C RNKDINKAIL HHHHCCHHHH H CCHHHHHHHH 5.22%MC0521278135in vitro
25626RGLQGSFEEL C RNKDINKAIL HHHHCCHHHH H CCHHHHHHHH 5.22%MC0522865876in vivo